Individual #00166718

ID_report -
Reference PubMed: Le Quesne Stabej 2012
Remarks Proband
Gender -
Consanguinity -
Country United Kingdom (Great Britain)
Population -
Age at death -
VIP -
Data_av -
Treatment -
Panel size 1
Diseases USH2
Owner name Maria Bitner-Glindzicz
Database submission license No license selected
Created by Maria Bitner-Glindzicz
Date created 2011-09-12 16:33:57 +02:00 (CEST)
Date last edited 2018-07-23 10:59:25 +02:00 (CEST)


Phenotypes

Usher syndrome, type II (USH-2) (USH2)   Add phenotype for this disease

AscendingPhenotype ID     

Diagnosis/Initial     

Diagnosis/Definite     

Phenotype details     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000131582 Usher syndrome - - Unknown - - - - - Maria Bitner-Glindzicz



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000167597 DNA SEQ - - - 6 Maria Bitner-Glindzicz



Variants

6 entries on 1 page. Showing entries 1 - 6.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
1 Paternal (confirmed) +/+ - pathogenic g.215824138C>T g.215650796C>T - - USH2A_000634 Heterozygous; Pathogenic PubMed: Le Quesne Stabej 2012 - - Germline - 0/878 controls +Hpy188I;+DdeI;+BspCNI; - - Maria Bitner-Glindzicz USH2A - - - - 65 NM_206933.2:c.14139G>A - r.(?) p.(Trp4713*) Fibronectin type-III 32 (4633-4730) - - - - - - - - - - - - -
1 Unknown -/- - benign g.216270469G>A g.216097127G>A - - USH2A_000038 Heterozygous; Neutral PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d - rs111033333 Germline - - -AcuI - - Maria Bitner-Glindzicz USH2A - - - - 22 NM_206933.2:c.4714C>T - r.(?) p.(Leu1572Phe) Laminin G-like 1 (1517-1709) - - - - - - - - - - - - -
1 Unknown +/+ - pathogenic g.216420437del g.216247095del 2299delG - USH2A_000001 Heterozygous; Pathogenic PubMed: Le Quesne Stabej 2012 - rs80338903 Germline - 2/846 controls none - - Maria Bitner-Glindzicz USH2A - - - - 13 NM_206933.2:c.2299del - r.(?) p.(Glu767Serfs*21) Laminin EGF-like 5 (747-794) - - - - - - - - - - - - -
5 Unknown -/? - benign g.89971369T>C g.90675552T>C - - GPR98_000026 heterozygous; pathogenicity not assessed PubMed: Le Quesne Stabej 2012 - - Germline - 0/96 controls +MwoI;+HpyCH4V;+Cac8I; - - Maria Bitner-Glindzicz GPR98 - - - - 24i NM_032119.3:c.5313+107T>C - r.(=) p.(=) - - - - - - - - - - - - - -
5 Paternal (confirmed) -/? ACMG likely benign g.90103438C>T g.90807621C>T - - GPR98_000124 heterozygous; UV1 PubMed: Le Quesne Stabej 2012 - - Germline - 0/878 controls +NcoI;+FatI;+NlaIII;+CviAII;+StyI;-HpyCH4III; - - Maria Bitner-Glindzicz GPR98 - - - - 73 NM_032119.3:c.14856C>T - r.(?) p.(=) - - - - - - - - - - - - - -
11 Unknown -/- - benign g.76919484G>A g.77208439G>A - - MYO7A_000376 Heterozygous; UV1 PubMed: Le Quesne Stabej 2012; USMA-USMA missense analysis USMA-missense variant in MSV3d - rs142293185 Germline - 2/846 controls +BsmI - - Maria Bitner-Glindzicz MYO7A - - - - 43 NM_000260.3:c.5866G>A - r.(?) p.(Val1956Ile) FERM 2 (1902-2205) - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.